Browsing by Author Eskens, Ferry
Showing results 1 to 3 of 3
| Issue Date | Title | Author(s) |
|---|---|---|
| 1-Jul-2021 | CX-072 (pacmilimab), a Probody® PD-L1 inhibitor, in advanced or recurrent solid tumors (PROCLAIM-CX-072): an open-label dose-finding and first-in-human study | Naing, Aung; Thistlethwaite, Fiona; Vries, Elisabeth G.E, de; Eskens, Ferry; Uboha, Nataliya; Ott, Patrick A.; Lorusso, Patricia; García Corbacho, Javier; Boni, Valentina; Bendell, Johanna; Autio, Karen A.; Randhawa, Manreet; Durm, Greg; Gil Martin, Marta; Stroh, Mark; Hannah, Alison L.; Arkenau, Hendrik-Tobias; Spira, Alexander |
| 1-Oct-2022 | Isatuximab plus atezolizumab in patients with advanced solid tumors: results from a phase I/II, open-label, multicenter study | Simonelli, M.; Garralda, E.; Eskens, Ferry; Gil Martin, M.; Yen, C. J.; Obermannova, R.; Chao, Y.; Lonardi, S.; Melichar, B.; Moreno, V.; Yu, M. L.; Bongiovanni, A.; Calvo, E.; Rottey, S.; Machiels, J. P.; Gonzalez Martin, A.; Paz Ares, L.; Chang, C. L.; Mason, W.; Lin, C. C.; Reardon, D. A.; Vieito, M.; Santoro, A.; Meng, R.; Abbadessa, G.; Menas, F.; Lee, H.; Liu, Q.; Combeau, C.; Ternes, N.; Ziti Ljajic, S.; Massard, C. |
| 1-Aug-2019 | Trastuzumab duocarmazine in locally advanced and metastatic solid tumours and HER2-expressing breast cancer: a phase 1 dose-escalation and dose-expansion study | Banerji, Udai; van Herpen, Carla M. L.; Saura, Cristina; Thistiethwaite, Fiona; Lord, Simon; Moreno Aguado, Víctor; Macpherson, Iain R.; Boni, Valentina; Rolfo, Christian; Vries Ege, Elisabeth G. E. de; Rottey, Sylvie; Geenen, Jill; Eskens, Ferry; Gil-Martín, Marta; Mommers, Ellen C.; Koper, Norbert P.; Aftimos, Philippe |